Listed by the USPTO as MARCETICH, ADAM M
Tech Center 3700 • Art Units: 3761 3781
This examiner grants 73% of resolved cases
MARCETICH, ADAM M is assigned to tech center 3700 and art unit 3761. The profile covers 1377 resolved cases, a 72.8% allowance rate, and a median of 1085 days to allowance. The 18.8% interview lift indicates that interviews are associated with improved allowance outcomes.
The recurring companies are 3M Company, ConvaTec Limited, and Essity Hygiene And Health Aktiebolag. The listed firms are Sullivan & Worcester LLP, TAFT STETTINIUS HOLLISTER LLP, and AMSTER, ROTHSTEIN & EBENSTEIN LLP. The substantial case record supports using these metrics as a meaningful prosecution reference.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19027372 | Methods Of Operating A Waste Collection Unit Including A Light Assembly | Non-Final OA | Stryker Corporation |
| 18890230 | ENDOLUMINAL TREATMENT DEVICES AND RELATED METHODS | Non-Final OA | Boston Scientific Scimed, Inc. |
| 18811236 | DEVICES AND METHODS FOR TRANSVASCULAR DRAINAGE OF FLUIDS IN AN INTRACRANIAL EXTRAVASCULAR SPACE | Non-Final OA | Mayo Foundation for Medical Education and Research |
| 18992036 | APPARATUS, SYSTEMS AND METHODS FOR PURGING AN EXUDATE CANISTER | Non-Final OA | Solventum Intellectual Properties Company |
| 18841223 | APPARATUSES, KITS, AND METHODS FOR TISSUE INTERFACE PLACEMENT | Final Rejection | Solventum Intellectual Properties Company |
| 18971810 | Medical Device, Medical Device Assembly Including the Same, and Method of Reconstitution of a Pharmaceutical Composition | Non-Final OA | Becton, Dickinson and Company |
| 18892192 | SYSTEM AND METHOD FOR A SHUNT | Non-Final OA | Medtronic Xomed, Inc. |
| 18247499 | ADJUSTABLE SHUNTS WITH RESONANT CIRCUITS AND ASSOCIATED SYSTEMS AND METHODS | Final Rejection | Shifamed Holdings, LLC |
| 18569711 | FLUID COLLECTION ASSEMBLIES EXHIBITING A RELATIVELY THIN SHAPE | Final Rejection | PUREWICK CORPORATION |
| 18820771 | DEVICES AND METHODS FOR CORNEA TREATMENT | Non-Final OA | D&D Biopharmaceuticals, LLC |
| 19544935 | BODY FLUID MOVEMENT SYSTEM WITH REMOTE PATIENT MONITORING | Final Rejection | Individual inventor |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy72.8% of resolved applications examined by Adam M Marcetich were allowed (1,377 resolved cases), compared with 57.7% across Art Unit 3761 over the last five years.
This examiner's interview lift is +18.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Adam M Marcetich took 1,085 days on average from filing to allowance.
Adam M Marcetich examines applications in Art Unit 3761 in Tech Center 3700 (Medical Devices & Mechanical Engineering).
